Status:
RECRUITING
A Registered Cohort Study on FSHD1
Lead Sponsor:
Ning Wang, MD., PhD.
Conditions:
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
Eligibility:
All Genders
Brief Summary
The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and ...
Detailed Description
The China FSHD1 patient registry is a nationwide, population-based, non-interventional, observational cohort clinical study of all age groups of genetically-confirmed FSHD1 patients from families (wit...
Eligibility Criteria
Inclusion
- Male or female subjects of all ages at baseline
- Subjects, with or without symptoms, with FSHD1 genetic confirmation through PFGE-based Southern blotting
- Unrelated healthy controls
Exclusion
- Decline to participate
- Other neuromuscular disease (such as Limb-girdle muscular dystrophy or Myotonic dystrophy)
- Serious systemic illness (such as heart, liver, kidney disease or major mental illness)
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2031
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04369209
Start Date
January 1 2001
End Date
December 1 2031
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350005